Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J
Department of Internal Medicine, University Hospital of Lund, Sweden.
J Intern Med. 1994 May;235(5):463-71. doi: 10.1111/j.1365-2796.1994.tb01104.x.
To perform an economic analysis of primary healing and healing with amputation in diabetic patients with foot ulcers.
A retrospective economic analysis based on a prospective study of consecutively presenting diabetic patients admitted to the Department of Internal Medicine because of foot ulcer.
A multidisciplinary foot-care team.
A total of 314 consecutively presenting diabetic patients with foot ulcers. Forty patients died before healing occurred. In those patients who healed primarily (n = 197) or after amputation (n = 77), a retrospective economic analysis was performed.
All patients were treated by a multidisciplinary foot care team consisting of diabetologist, orthopaedic surgeon, diabetes nurse, podiatrist and orthotist both as in- and out-patients. The patients were followed by the team from admittance until final outcome, i.e. primary healing or healing with amputation or death.
Data from both the prospectively collected patient material and from patient records were used to estimate the cost for hospital care, antibiotics, surgery, out-patient care, staff attendance, drugs and material for ulcer dressings, and orthopaedic appliances.
The total costs were SEK 51,000 (3000-808,000) for patients with primary healing and SEK 344,000 (27,000-992,000) for healing with amputation. Costs for in-patient care were 37% of total average costs for primary healing and 82% for patients with amputation. The costs for topical treatment of the ulcers in out-patient care were 45% of the total average cost for primary healed and 13% for patients who healed with amputation. The costs for products used for ulcer dressings were 21% of total costs for topical treatment, i.e. 9% and 3% of total average costs for primary healing and healing with amputation, respectively. Costs for visits to the foot care team, antibiotics and orthopaedic appliances were low in relation to total costs.
Treatment of diabetic patients with foot ulcers in a multidisciplinary system was associated with relatively low costs. Healing with amputation was associated with high costs mainly due to multiple and extended hospitalization. These findings indicate the potential cost savings of preventive and multidisciplinary foot care.
对糖尿病足溃疡患者一期愈合和截肢后愈合进行经济学分析。
基于一项对因足部溃疡入住内科的连续就诊糖尿病患者的前瞻性研究进行回顾性经济学分析。
一个多学科足部护理团队。
共314例连续就诊的糖尿病足溃疡患者。40例患者在愈合前死亡。对那些一期愈合(n = 197)或截肢后愈合(n = 77)的患者进行了回顾性经济学分析。
所有患者均由一个多学科足部护理团队治疗,该团队由糖尿病专家、骨科医生、糖尿病护士、足病医生和矫形师组成,患者作为门诊和住院患者接受治疗。该团队从患者入院直至最终结局,即一期愈合、截肢后愈合或死亡,对患者进行随访。
前瞻性收集的患者资料和患者记录中的数据均用于估算医院护理、抗生素、手术、门诊护理、医护人员出诊、溃疡敷料用药及材料以及矫形器具的费用。
一期愈合患者的总费用为51,000瑞典克朗(3000 - 808,000),截肢后愈合患者的总费用为344,000瑞典克朗(27,000 - 992,000)。住院护理费用占一期愈合患者总平均费用的37%,占截肢患者的82%。门诊护理中溃疡局部治疗费用占一期愈合患者总平均费用的45%,占截肢后愈合患者的13%。用于溃疡敷料的产品费用占局部治疗总费用的21%,即分别占一期愈合和截肢后愈合患者总平均费用的9%和3%。足部护理团队出诊、抗生素和矫形器具的费用与总费用相比很低。
在多学科系统中治疗糖尿病足溃疡患者的成本相对较低。截肢后愈合成本高昂,主要是由于多次且长期住院。这些发现表明预防性和多学科足部护理具有潜在的成本节约作用。